![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
Erythocyte mean corpuscular volume (MCV) rises dramatically in the presence of zidovudine, which currently is the only anti-retroviral licensed for the treatment of HIV infected individuals. This paper reports the long-term effects of zidovudine on MCV levels and discusses the potential for using MCV levels as a measure of compliance to study medication in clinical trials of zidovudine.